Russia approves vaccine before late-stage testing

August 12, 2020 Latest News

This is a preview of subscriber content

Subscribe now to continue reading.

BioNTech says the investigative COVID-19 vaccine it is developing with Pfizer could be submitted for approval by October while Russian president Vladimir Putin says the country's vaccine is 'effective enough' to be distributed. …

Subscribe now to continue reading.

Latest Video

AusBiotech appoints experienced Sanofi leader as its new chief executive
April 23, 2024 - Latest News
'The Pharmac system again, over about 33 years old, hasn’t really changed and evolved'
April 24, 2024 - Latest News
Don't be alarmed by a flat or declining forecast, because it will rise over time
April 22, 2024 - Latest News
Should principles such as 'equity' and 'opportunity cost' be applied consistently or not at all?
April 23, 2024 - Latest News
Rare Cancers Australia welcomes new appointments to its board of directors
April 23, 2024 - Latest News

Russia approves vaccine before late-stage testing

This is a preview of subscriber content

Latest Video

Most Read

AusBiotech appoints experienced Sanofi leader as its new chief executive

'The Pharmac system again, over about 33 years old, hasn’t really changed and evolved'

Don't be alarmed by a flat or declining forecast, because it will rise over time

Should principles such as 'equity' and 'opportunity cost' be applied consistently or not at all?

Rare Cancers Australia welcomes new appointments to its board of directors

New Stories

Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate

Novartis nominates ex-BMS chief executive as its new chair

'The Pharmac system again, over about 33 years old, hasn’t really changed and evolved'

AusBiotech appoints experienced Sanofi leader as its new chief executive

Should principles such as 'equity' and 'opportunity cost' be applied consistently or not at all?

Rare Cancers Australia welcomes new appointments to its board of directors

BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics

Sign In

Russia approves vaccine before late-stage testing

This is a preview of subscriber content

Latest Video

Most Read

AusBiotech appoints experienced Sanofi leader as its new chief executive

'The Pharmac system again, over about 33 years old, hasn’t really changed and evolved'

Don't be alarmed by a flat or declining forecast, because it will rise over time

Should principles such as 'equity' and 'opportunity cost' be applied consistently or not at all?

Rare Cancers Australia welcomes new appointments to its board of directors

Follow Us

New Stories

Tour de Cure backs further development of Noxopharm's preclinical brain cancer candidate

Novartis nominates ex-BMS chief executive as its new chair

'The Pharmac system again, over about 33 years old, hasn’t really changed and evolved'

AusBiotech appoints experienced Sanofi leader as its new chief executive

Should principles such as 'equity' and 'opportunity cost' be applied consistently or not at all?

Rare Cancers Australia welcomes new appointments to its board of directors

BMS and Australian venture capital firm back immunotherapy company Pathios Therapeutics